Our people

Chairman of the Investment Committee.

Mr Campbell has been a Director of the Company since December 1998. He is Chairman Emeritus of Goldman Sachs Australia (formerly Goldman Sachs JBWere). Mr Campbell was formerly Chairman and Chief Executive of Goldman Sachs JBWere. He is a former Chairman of Australian Foundation Investment Company Limited (AFIC) and AMCIL Limited and a former Director of Djerriwarrh Investments Limited.

Managing Director and Member of the Investment Committee.

Mr Freeman was appointed as Managing Director in January 2018 having been Chief Investment Officer since joining the Company in February 2007. Prior to this he was a Partner with Goldman Sachs JBWere where he spent 12 years advising the Investment Companies on their investment and dealing activities. He has a deep knowledge and experience of investments markets and the Company’s approaches, policies and processes. He is also Managing Director of AFIC, Djerriwarrh Investments Limited and AMCIL Limited.

Member of the Audit and Investment Committees.

Mr Campbell is a Company Director who was appointed a Director of the Company in November 2007. He is a non-executive Director and Chairman of BWX Limited. He was formerly Managing Director of GUD Holdings Limited and Deputy President of Australian Industry Group (VIC). He was also formerly Managing Director of Pacific Dunlop Cables Group.

Member of the Audit Committee.

Dr Jackie Fairley was appointed a Director of the Company in February 2018. She is currently the Chief Executive Officer of Starpharma Holdings Ltd, having held this position since 2006. Dr Fairley has more than 30 years of operational experience in the pharmaceutical and biotechnology industries working in business development and senior management roles in companies which include CSL and Faulding/Hospira (now part of Pfizer). Dr Fairley is also Chair of the Invest Victoria Advisory Board, a Board member of the Melbourne Business School and is an adviser to the Carnegie Innovation Fund.

Dr Fairley was formerly a Board member of the Melbourne Business School and a past member of the Australian Federal Government’s Commonwealth Science Council and Pharmaceutical Industry Working Group and the Australian Federal Ministerial Biotechnology Advisory Council.

Member of the Audit and Investment Committees.

Annette is the global CEO and Managing Partner at MinterEllison, a role she has held since October 2018. Annette's executive career has included a range of senior roles with Ernst & Young and, prior to EY, Annette was Senior Project Director at the International Accounting Standards Board (IASB). She joined the IASB at its inception in 2001 and is one of the founding developers of International Financial Reporting Standards (IFRS).

Annette has been a Non-Executive Director and Chair of the Finance, Audit and Risk Committee of the Melbourne Business School since 2010. She was appointed in 2019 as a member of The University of Melbourne's Faculty of Business and Economics Board, and in 2020 joined Monash University's Industry Council of Advisors. She has been a member of the Business Council of Australia's Economic Policy and Competitiveness Committee since 2018. Annette is also currently a Non-Executive Director of Law Firms Australia and of the Corporate Mental Health Alliance Australia.

Chairman of the Audit Committee. Member of the Investment Committee.

Mr Meiklejohn was appointed a Director of the Company in March 2006. He is a former Chairman of PaperlinX Limited, SPC Ardmona Limited, a former Deputy Chairman of GasNet Australia Limited, a former President of the Melbourne Cricket Club, a former Director of WMC Resources Limited, Coca-Cola Amatil Limited, One Steel Limited and ANZ Banking Group Limited. He was formerly Chief Financial Officer and a Director of Amcor Limited.

Member of the Investment Committee.

Greg recently retired from the Board of JB Hi-Fi Limited after being a Non-Executive Director for 12 years including 8 years as Non-Executive Chairman. Greg was also Chair of the JB Hi-Fi Remuneration Committee. Mr Richards has over 25 years experience in the investment banking industry, with 19 years at JBWere and Goldman Sachs JBWere, where he was an equity partner for 17 years, working primarily in equity capital markets. Greg was previously Non-Executive Chairman of Vitaco Holdings Limited.

Mr Driver joined the Company in January 2003. Previously, he was with National Australia Bank Ltd for 18 years in various roles covering business strategy, marketing, distribution, investor relations and business operations. Mr Driver was formerly Chairman of Trust for Nature (Victoria).

Mr Porter joined the Company in January 2005. He is a Chartered Accountant and has had over 24 years’ experience in accounting and financial management both in the United Kingdom with Andersen Consulting and Credit Suisse First Boston, and in Australia where he was Regional Chief Operating Officer for the Corporate and Investment Banking Division of CSFB. He is the immediate former Chair of The Group of 100 (G100), the peak body for CFOs and remains on the Board, is a Director of the Auditing and Assurance Standards Board (AUASB) and a Director of the Anglican Foundation.

Mr Rowe joined the Company in July 2016. He is a Chartered Secretary with over 15 years of experience in corporate governance with a particular focus in listed investment companies. He was previously a corporate governance advisor at a professional services firm which included acting as Company Secretary for three ASX listed companies. Prior to that Matthew was the Company Secretarial Manager for a Funds Management company based in the UK.